Physician profile
Edwin Lee Robles
NPI 1437197423
$3,567.60
in general payments reported to CMS, 2019-2025
37 companies · $639 in 2025
The $639 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $181 · 2021: $533 · 2022: $476 · 2023: $620 · 2024: $809 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,068.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $848.33 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $441.26 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $277.48 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $213.08 | 2019-2025 | |
| Glaxosmithkline, LLC. | $199.50 | 2020-2025 | Trelegy Ellipta, Arexvy, Bexsero |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.49 | 2019-2024 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $128.14 | 2019-2025 | Eliquis, Camzyos |
| Exact Sciences Corporation | $118.75 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $110.95 | 2020-2025 | Airsupra, Farxiga |
| Merck Sharp & Dohme LLC | $105.80 | 2019-2024 | Gardasil 9, Gardasil, Vaxelis |
| Astellas Pharma US INC | $105.31 | 2020-2024 | Veozah |
| Amgen INC. | $82.84 | 2021-2025 | Otezla, Repatha, Repatha |
| Dexcom, INC. | $81.40 | 2021-2024 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $63.84 | 2019-2024 | Xarelto |
| Axsome Therapeutics, INC. | $61.06 | 2024-2025 | Auvelity |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Robles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.